Aclarion (NASDAQ:ACON – Get Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Aclarion to post earnings of ($50.00) per share and revenue of $0.02 million for the quarter.
Aclarion Stock Down 3.5 %
ACON stock opened at $0.76 on Thursday. The stock’s 50 day simple moving average is $2.84 and its 200 day simple moving average is $38.40. Aclarion has a fifty-two week low of $0.61 and a fifty-two week high of $231.15.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a research note on Friday, December 13th. Ascendiant Capital Markets dropped their price target on Aclarion from $502.50 to $435.50 and set a “buy” rating on the stock in a research note on Wednesday, November 27th.
Aclarion Company Profile
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing In Automotive Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Stock Analyst Ratings and Canadian Analyst Ratings
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
